Navigation Links
Weill Cornell Medical College Announces First Commencement of Its New Medical School Graduates in Doha, Qatar, May 8, 2008
Date:5/7/2008

Cornell Is First American University to Give the M.D. Degree Outside of the

United States

NEW YORK, May 7 /PRNewswire/ -- Weill Cornell Medical College announced today that its branch campus, Weill Cornell Medical College in Qatar (WCMC-Q), part of Cornell University and the first American medical school ever established overseas, will graduate its first class in Doha, Qatar, on May 8, 2008.

The graduating class of 15 students - 9 women and 6 men - represents seven different nationalities. These include Qatar, Bosnia, India, Jordan, Nigeria, Syria, Palestine and the U.S. In attendance at the Qatar commencement will be senior officials from the health, public and private sectors in Qatar and the region; leaders from Qatar Foundation for Education, Science and Community Development; leaders from Hamad Medical Corporation (HMC), the state health service provider; and dignitaries from Cornell University and from Weill Cornell Medical College in New York City.

The keynote speaker will be Dr. David Skorton, President of Cornell University; the student commencement speaker will be Jehan Al Rayahi, a female Qatari student selected by her classmates. The Qatar graduates will also attend the Medical College's general commencement at Carnegie Hall in New York City on May 29, 2008.

"Weill Cornell Medical College in Qatar is one of our institution's proudest achievements," said Dr. David Skorton, President of Cornell University. "Its development, and the plans for the opening of the Sidra Medical and Research Center by the Qatar Foundation, will make world-class medical care available to the people of Qatar. I offer my sincere congratulations to this notable first class of graduates."

The program in Qatar replicates the curriculum taught at Weill Cornell Medical College, with WCMC-Q students introduced to patient care from the earliest stage of their medical education. This takes place in the hospitals and cl
'/>"/>

SOURCE Weill Cornell Medical College
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Weill Cornell receives funding to study creation of new elder abuse center
2. Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer
3. $50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center
4. NewYork-Presbyterian/Weill Cornell creates world-class cancer center
5. Weill Cornell receives $2.4 million in grants from Gates Foundation to fight tuberculosis
6. White House awards Weill Cornells Bruce McCandliss highest honor for early career scientists
7. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
8. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
9. By color-coding atoms, new Cornell electron microscope promises big advance in materials analysis
10. Healthy restaurants help make us fat, says a new Cornell study
11. Medical research is essential to improving the economy and bettering lives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...onal Pediatric AIDS Initiative Will Improve... WASHINGTON, Aug. 29 /PRNewswire-FirstCall/ -- Th... government, Baylor College of Medicine, the,gover...S. President,s,Emergency Plan for AIDS Relief (PEP... improve care and treatment for children with HIV/...
(Date:8/29/2008).../ -- Conseco Insurance Company, a life,and health ...y of its new,indexed universal life insurance pro...de potential with downside protection., ConsecoLi... offers the,opportunity for long-term cash buildup...ents can customize their coverage levels with eigh...
(Date:8/29/2008)...SNewswire/ -- The U.S. Department of,Labor propose...public to,see exactly what goes into agency risk a...r http://edocket.access.gpo.gov/2008/E8-20179.htm...st available evidence and,scientific data are used...ards regulating occupational exposure to toxins in...
(Date:8/29/2008)...SNewswire/ -- The following is a,statement by Matt... Kids:, For the second time in a month, Philip Mo... and promotion of a concert in a developing countr...ngaging in cigarette,marketing that appeals to chi...s been forced to withdraw from,an August 30 reunio...
Breaking Medicine News(10 mins):Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 2Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 3Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 4Health News:ConsecoLifeOptions Launched by Conseco Insurance Company as New Universal Life Product 2Health News:Notice of Proposed Rulemaking on U.S. Department of Labor's Risk Assessment Procedures Published in Federal Register 2Health News:Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action 2
...that the magnets that are sold in the market does ...t health problems//. Magnet that are advertised ov...ot posses any theoretical and experimental value. ...ful athletes mainly to relive pain but the researc...
...lized medicine, one should reevaluate new medicine...ry//, Ph.D., Dr. Berry, professor and chair of t...tics at The University of Texas M. D. Anderson Can...linical trials are designed and conducted in the U...
... Woodruff (R) said he had filed a bill (HB 1096) t...s delivering the baby// would endanger the life or... law to make performing an abortion a Class C felo...ar prison sentence. Woodruff said he introduced t...
...o have late children but fear loss in fertility ca...and can use it when they want their children.// Th...ertility to store their embryo without fear of loo...ll be very useful for cancer patients who are plan...
Other Medicine News:Health News:Does Magnet Therapy Posses Healing Powers? 2Health News:New Generation Clinical Trials Could Save Time And Money, Improve Patient Care 2
(Date:8/27/2008)...of Bucks, Delaware, Montgomery,Philadelphia Count...ire/ -- After encouraging,results following the fi...Environmental Protection will continue its efforts...squito-borne West Nile virus., Targeted aerial tr...idnight in portions of Bucks, Delaware, Montgomery...
(Date:8/27/2008)...an and prednisone arm demonstrated a, significant... response -, CAMBRIDGE, Mass., Aug. 27 /PRNewswir...y announced the publication of results from the 68... this week,s edition of the,New England Journal of...al,benefit and a 30 percent complete remission (CR...
(Date:8/27/2008)...wire-FirstCall/ --, - Oralair(R) Grasses 300IR Hi...c Study Conducted in an Allergen Challenge Chamber... results of a new study,conducted in an Allergen C...Grasses included 86 adult patients exposed to,gras...ons: 1 week, 1 month,2 and 4 months without a tit...
(Date:8/27/2008)...-52 trial, expected by mid-2009 - - Data from sec... -, ROCKVILLE, Md., Aug. 27 /PRNewswire-FirstCall...today announced it has completed enrollment,and in...l Phase 3,randomized clinical trials of LymphoStat... lupus erythematosus (SLE). Belimumab is being dev...
Breaking Medicine Technology:DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 2DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Leading Natural Cosmetics Company Supports Breast Cancer Survivors 13433 1Leading Natural Cosmetics Company Supports Breast Cancer Survivors 13433 2Leading Natural Cosmetics Company Supports Breast Cancer Survivors 13433 3Leading Natural Cosmetics Company Supports Breast Cancer Survivors 13433 4Scientists find mercury threatens next generation of loons 13432 1Scientists find mercury threatens next generation of loons 13432 2New potential drug target for the treatment of atherosclerosis 13430 1New potential drug target for the treatment of atherosclerosis 13430 2New potential drug target for the treatment of atherosclerosis 13430 3Smith 26 Nephew Announces Breakthrough VERILAST 28TM 29 Technology 13428 1Smith 26 Nephew Announces Breakthrough VERILAST 28TM 29 Technology 13428 2Smith 26 Nephew Announces Breakthrough VERILAST 28TM 29 Technology 13428 3Smith 26 Nephew Announces Breakthrough VERILAST 28TM 29 Technology 13428 4
...nt Therapy Significantly,Improved Absorption of Fa... and DAYTON, Ohio, April 04, 2007 /PRNewswire/ --,... today unveiled,data from two phase III clinical t...formerly EUR-1008, for the treatment of,Exocrine P...g,Administration (FDA) granted fast track status f...
...2007 - CytRx Corporation,(NASDAQ:CYTR) today annou...studies indicating that CytRx,s lead drug candidat...ry of sensory and,motor function in an experimenta...hheld as long as 48 hours after stroke was,induced...ata,announced by CytRx in December 2006. Orally-ad...
Other Medicine Technology:Eurand Announces Positive Phase III Clinical Study Results 2Eurand Announces Positive Phase III Clinical Study Results 3Eurand Announces Positive Phase III Clinical Study Results 4Eurand Announces Positive Phase III Clinical Study Results 5CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 2CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 3CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 4CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 5
The EZY Close post op shoe's flap-on-flap closure provides a secure fit and can accommodate even the bulkiest of dressing. Perfect for older patients with limited hand dexterity.
This popular post op shoe provides quality care at an outstanding value. The semi-rigid outsole provides stability and minimizes flexure.
...for patients who experience severe plantar fasciit... fibrous tissue that can occur after rest periods ...ing. The continuous tension and fixed position red...d helps stretch the Achilles tendon to provide rel...
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
Medicine Products: